Note: Ingredients listed on restricted chemical lists
EC/CAS
204-872-5/127-91-3
Name of the chemical
β-pinene
Concentration
1-<3%
EC/CAS
809-930-9/1330-78-5
Name of the chemical
Tris(methylphenyl) phosphate
Concentration
0,1-1%
EC/CAS
204-881-4/128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
0,15-< 1%
General Information
Version
1.0
Revision date
2024-04-26
Product name
DAPHNE HERMETIC OIL FVC56EA
supplier name
WAECO Germany WSE GmbH
Emergency telephone
+49 (0) 700 / 24 112 112, +1 872 5888271
Icons in SDS
Company Information
company name
WAECO Germany WSE GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@waeco.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H411
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
H411
Toxic to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
Health hazards
Skin sensitisation, Category 1 H317 May cause an allergic skin reaction.
Environmental hazards
Hazardous to the aquatic environment – H411 Toxic to aquatic life with long lasting effects. Chronic Hazard, Category 2 Full text of H- and EUH-statements: see section 16
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Signal word
Warning
Contains
2-ethylhexyl)oxy]methyl] oxirane; Pin-2(10)-ene
Hazard statements
H317 May cause an allergic skin reaction. H411 Toxic to aquatic life with long lasting effects.
Prevention
P273 Avoid release to the environment. P280 Wear protective gloves
Response
P302+P352 IF ON SKIN: Wash with plenty of soap and water. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P391 Collect spillage.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII. This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII. The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %